Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Magnitude and temporal trends of leprosy relapse in the state of Ceará, Brazil in the period 2001-2018.

Nzundu Boigny R, Florêncio CMGD, Cavalcante K, et al. Revista da Sociedade Brasileira de Medicina Tropical. 2021;
Download PDF
Publication

Revised estimates of leprosy disability weights for assessing the global burden of disease: A systematic review and individual patient data meta-analysis.

Chandran S, Tiwari A, Lustosa A, et al. PLoS neglected tropical diseases. 2021; 15 (3) : e0009209.
Download PDF
Publication

Chronic Care for Neglected Infectious Diseases: Leprosy/Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease

Pan American Health Organization . 2021;
Download PDF
Publication

A family-based intervention for prevention and self-management of disabilities due to leprosy, podoconiosis and lymphatic filariasis in Ethiopia: A proof of concept study.

van 't Noordende A, Aycheh M, Tadesse T, et al. PLoS neglected tropical diseases. 2021; 15 (2) : e0009167.
Download PDF
Publication

Healthcare professionals’ perceptions of community-based rehabilitation in KwaZulu-Natal, South Africa

Blose SB, Doeraj S, Padia S, et al. AOSIS. African Journal of Primary Health Care & Family Medicine. 2021;
Download PDF
Publication

Quality of life of leprosy patients in Sabah.

Gan T, Voo S. The Medical journal of Malaysia. 2021; 76 (1) : 56-60.
Download PDF
Publication

Correlation between Disability and Stigma on Leprosy Patient at General Public Hospital of Daha Husada Kediri

Mahanani S, Idris DNT. Medico Legal Update. 2021; 21 (1) : 995-999.
Download PDF
Publication

Perfil das reações Hansênicas e acometimento de nervo(s) periférico(s) nos pacientes admitidos e tratados na Unidade de Saúde Dr. Ilion Fleury no município de Anápolis, entre 2011 e 2013

Filho SD, Barbosa MF, Sacchetim S C, et al. Brazilian journal of health review. 2021; 4 (1) : 53-71.
Download PDF
Publication

Evaluation of nerve growth factor serum level for early detection of leprosy disability.

Widasmara D, Menaldi S, Turchan A. The Pan African medical journal. 2020;
Download PDF
Publication

Activity Limitation of People Affected by Leprosy in an Endemic District in West Bengal, India

Govindharaj P, Srinivasan S, Darlong J. Disability, CBR & Inclusive Development. 2020; 31 (3) : 46–63.

Pagination

  • Previous page ‹‹
  • Page 38
  • Next page ››
Subscribe to Disability

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD